Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Puma Biotechnology Inc (NASDAQ:PBYI)

87.50
Delayed Data
As of Jun 23
 +1.05 / +1.21%
Today’s Change
27.64
Today|||52-Week Range
92.00
+185.02%
Year-to-Date
Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys
Jun 21 / Zacks.com - Paid Partner Content
3 Biotech Stocks That More than Doubled Year to Date
Jun 19 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Puma (PBYI) Stock Surges as Neratinib Nears FDA Approval
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close86.45
Today’s open85.50
Day’s range84.35 - 87.85
Volume1,124,649
Average volume (3 months)1,523,845
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-11.28%
Earnings growth (this year)+5.57%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book15.36

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+17.81+46.56%
ICPTIntercept Pharmaceut...+1.72+1.32%
SAGESAGE Therapeutics In...-0.71-0.84%
CBPOChina Biologic Produ...-0.73-0.65%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$1.91
Annual revenue (last year)$0.00
Annual profit (last year)-$276.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts